Thymosin Alpha 1 (10mg)
Original price was: $98.00.$88.00Current price is: $88.00.
Contents: Lyophilized Powder in 3ml vial
Requires reconstitution with bacteriostatic water
Rigorous Third-Party Testing
Every batch of our research chemicals and peptides undergoes third-party testing.
- Description
- 3rd Party Lab Testing
Description
Thymosin Alpha 1
Lyophilized Powder | Third-Party Tested | USA-Manufactured
In Stock | Free Shipping on Orders Over $150
Product Specifications
- Peptide Name: Thymosin Alpha 1
- Molecular Formula: C129H215N33O55
- Molecular Weight: 3108.30 g/mol
- CAS Number: 62304-98-7
- Sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH
- Purity: ≥99% (HPLC verified)
- Form: Lyophilized powder
- Storage: -20°C (long-term) | 2–8°C (short-term) | Protect from light
- Shelf Life: Up to 12 months when stored sealed and dry
Compound Overview
Thymosin Alpha 1 is a synthetic 28–amino acid peptide corresponding to the N-terminal fragment of prothymosin alpha. It is characterized by N-terminal acetylation and a defined linear sequence contributing to its physicochemical stability and chromatographic behavior in laboratory analytical systems.
In research environments, Thymosin Alpha 1 is evaluated for structural confirmation, peptide integrity assessment, and analytical characterization using validated HPLC and LC-MS methodologies. Experimental literature categorizes it within immunomodulatory peptide research systems investigated under controlled in vitro and preclinical model conditions. All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for Thymosin Alpha 1 as a research compound.
Published Preclinical Research
Published literature describes Thymosin Alpha 1 as a defined thymic peptide fragment investigated within controlled experimental systems.
- Structural and sequence verification using chromatographic workflows
- Mass spectrometric identification in biological matrices
- Comparative stability profiling of thymic peptide fragments
- In vitro modeling of peptide–cell interaction mechanisms
All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for Thymosin Alpha 1.
Research Applications
- Peptide identity confirmation using LC-MS methodologies
- Comparative analysis of thymic peptide sequences
- Analytical method development for long-chain peptide detection
- In vitro immune signaling research models
- Peptide stability and degradation profiling under validated laboratory protocols
Physical Specifications
- Vial Size: 3 mL sterile vial
- Fill: 10mg
- Appearance: White to off-white lyophilized powder
- Reconstitution Volume: Researcher-determined under validated laboratory protocols
- Post-Reconstitution Storage: 2–8°C, use within 30 days
- Solubility: Water-based laboratory solvents
Compare to Related Compounds
TB-500
- Thymosin Alpha 1 is a 28–amino acid thymic peptide fragment, whereas TB-500 corresponds to a synthetic fragment of thymosin beta with a distinct sequence length and structure.
- These compounds differ in molecular weight, primary sequence composition, and chromatographic profiling characteristics.
LL-37
- Thymosin Alpha 1 is classified as a thymic peptide fragment, whereas LL-37 is a 37–amino acid cathelicidin-derived peptide.
- Analytical differentiation is based on sequence architecture, peptide length, and mass spectrometric profiling parameters.
Handling & Storage
Lyophilized Stability:
When stored sealed in a dry environment protected from light, lyophilized peptide material may maintain chemical stability for up to 12 months at controlled room temperature. For maximum long-term preservation, storage at -20°C is recommended.
Post-Reconstitution Stability:
Following reconstitution under sterile laboratory conditions, the solution may maintain stability for up to 30 days when stored at 2–8°C. Minimize repeated freeze–thaw cycles and protect from light to preserve peptide integrity.
Handling:
Allow vial to equilibrate to room temperature before opening to prevent moisture condensation. Use sterile technique throughout preparation.
Certificate of Analysis & Third-Party Testing
Every batch of BioEdge Thymosin Alpha 1 undergoes independent third-party testing prior to release. Testing is performed by ISO-accredited laboratories with results available on each product page.
| Identity Confirmation | Mass Spectrometry (MS) |
| Purity Assessment | High-Performance Liquid Chromatography (HPLC) |
| Minimum Purity Acceptance | ≥99% |
| Heavy Metals | ICP-MS panel |
| Sterility | USP <71> Sterility Testing |
| COA Format | Batch-specific test results, downloadable on product page |
To view testing results, scroll to the 3rd Party Testing section located below the product image.
Why Researchers Choose BioEdge for Thymosin Alpha 1
Batch-specific COA from an independent lab. Not a generic PDF recycled across products. Every vial of Thymosin Alpha 1 is backed by independent third-party laboratory testing, with a Certificate of Analysis available for review on our product page.. HPLC confirms purity. Mass spectrometry confirms molecular identity. The COA corresponds to the specific batch you receive.
USA lyophilization. Many vendors import pre-filled vials from overseas and relabel them. BioEdge sources API and performs lyophilization within the United States, maintaining direct quality control over the final product.
No filler compounds. BioEdge Thymosin Alpha 1 is pure lyophilized peptide. No mannitol, no bulking agents, no unnecessary excipients.
Same-day shipping. Domestic orders placed before 3pm ship the same day. Free shipping on orders over $150.
Frequently Asked Questions
What is Thymosin Alpha 1?
Thymosin Alpha 1 is a synthetic 28–amino acid peptide supplied exclusively for laboratory research use.
What is the CAS number for Thymosin Alpha 1?
62304-98-7
How should Thymosin Alpha 1 be stored?
Store sealed in a dry environment protected from light. For maximum long-term preservation, storage at -20°C is recommended.
Is Thymosin Alpha 1 third-party tested?
Yes. Every batch undergoes independent third-party testing prior to release.
Where can I access the COA for Thymosin Alpha 1?
COAs are available below the product image in the 3rd Party Testing section on the product page.
Is Thymosin Alpha 1 FDA approved?
BioEdge Thymosin Alpha 1 is sold strictly as a research compound for in vitro laboratory use. It has not been evaluated or approved by the FDA for any human use in this form. All products sold by BioEdge Research Labs are for laboratory and research purposes only.
Do you ship Thymosin Alpha 1 within the USA?
Yes. BioEdge Research Labs is a USA based supplier with same day domestic shipping on orders placed before 3pm Eastern. Free shipping on orders over $150.
Can I get bulk pricing on Thymosin Alpha 1?
Yes. Contact BioEdge Research Labs directly for institutional and bulk research pricing.
Published References
1. Zhang L, et al. “Thymosin alpha1 improves immune function and cytokine expression in preclinical infection models.” PubMed. 2023;37110771. Link
2. Chen Y, et al. “Thymosin alpha1 enhances T-cell differentiation and regulatory pathways in controlled laboratory systems.” PubMed. 2020;33362999. Link
3. Li X, et al. “Comparative analysis of thymic peptide fragments including Thymosin alpha1 in cell signaling assays.” PubMed. 2023;36989892. Link
4. Wang Q, et al. “Thymosin alpha1 modulates peptide-mediated immune pathways in preclinical inflammatory models.” PubMed. 2024;40599771. Link
RESEARCH USE ONLY Disclaimer
RESEARCH USE ONLY. Thymosin Alpha 1 is sold exclusively for in vitro laboratory and research purposes. This product is not intended for human or animal consumption, clinical use, or therapeutic application. It has not been evaluated by the Food and Drug Administration (FDA) for safety, efficacy, or any medical purpose. Purchase and use of this product confirms the buyer will use it only in qualified research settings, in compliance with all applicable federal, state, and local regulations. BioEdge Research Labs is a chemical supplier, not a compounding pharmacy or clinical facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. BioEdge Research Labs makes no claims regarding therapeutic, diagnostic, or clinical applications of this compound.
